Dirty dozen: WHO lists 12 pathogens in need of research

The World Health Organization (WHO) has released a list chronicling antibiotic-resistant “priority pathogens” to guide research and development of new antibiotics.

The list is split into three categories, classifying the need for new antibiotics by critical, high and medium priority. The WHO hopes the list will further push research and development (R&D) of new antibiotics to assist in the fight against antibiotic-resistant infections.

"This list is a new tool to ensure R&D responds to urgent public health needs," said Marie-Paule Kieny, PhD, the WHO assistant director-general for health systems and innovation. "Antibiotic resistance is growing, and we are fast running out of treatment options. If we leave it to market forces alone, the new antibiotics we most urgently need are not going to be developed in time."

Read the full article by clicking the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.